We are committed to finding a cure for WM.

News

Abstract: BeiGene Initiates Global Phase III Trial of the BTK Inhibitor BGB-3111 in Waldenström’s Macroglobulinemia

Go to website – http://pipelinereview.com/index.php/2017012563690/Small-Molecules/BeiGene-Initiates-Global-Phase-III-Trial-of-the-BTK-Inhibitor-BGB-3111-in-Waldenstroms-Macroglobulinemia.html

PDF – BeiGene Initiates Global Phase III Trial of the BTK Inhibitor BGB-3111 in Waldenström’s Macroglobulinemia | Small Molecules | News Channels

BeiGene Initiates Global Phase III Trial of the BTK Inhibitor BGB-3111 in Waldenström’s… Continue reading

Mayo Clinic Update on Diagnosis and Treatment of WM

 

 

 

 

 

This open source article was recently published in the American Journal of Hematology. 

Waldenström macroglobulinemia: 2017 update on diagnosis, risk stratification, and management

Authors

  • Morie A. Gertz
  • First published: 

 

WEBSITE

PDF